Anthropic inks US$12bn deal with Akamai
Anthropic PBC signed an US$11.6 billion, seven-year deal with Akamai Technologies Inc for computing power. This agreement builds on a previous US$1.8 billion computing deal between the two firms. Akamai will supply Anthropic with central processing units (CPUs) to support its soaring Claude software demand. Akamai also issued a warrant for Anthropic to buy 7.7 million shares of common stock at US$111.33 per share.
Akamai’s US$11.6 billion deal with Anthropic is not just a major revenue win; it is a fundamental shift in Akamai’s business model. The company, known for content delivery and cybersecurity, now sees its cloud computing segment growing "extremely fast." This capital expenditure for CPUs and networking gear, estimated at US$5.5 billion, is more than six times last year’s total spending. Akamai projects US$1.7 billion in annual revenue from Anthropic by 2028.
The deal’s structure, including a warrant for Anthropic to acquire Akamai shares, reflects a growing trend of circular AI investments. Wall Street investors are concerned these pacts obscure real demand for AI services. For Asia, this model could reshape how regional cloud providers compete. Companies like Alibaba Cloud and Tencent Cloud may face pressure to offer similar equity-linked deals to secure major AI clients, straining their own capital expenditure plans.
The thing to watch is whether other major AI developers demand similar equity stakes from their cloud providers. Akamai’s CEO Tom Leighton called the warrant a "serious step." If this becomes standard practice, it will change how Asian hyperscalers structure their partnerships. The deal’s success for Akamai hinges on its ability to deliver the promised computing power efficiently through 2028.
Related reading
6 stories
Anthropic faces court setback on US supply chain risk label
Anthropic's deal with Akamai is a major development for the AI firm, which recently faced a US supply chain risk label.

Microsoft packages business AI in single app as it tries to compete with Anthropic
This Akamai deal highlights the intense competition in the AI space, where Microsoft is also vying with Anthropic.

China’s biotech firms move up value chain as drug deals evolve beyond licensing: analysts

Pinglu Canal underscores China’s turn toward Southeast Asia

OpenAI wants you to use AI — but not to train its AI

